Sulaiman Alalwani

Summer project

Bioinformatics Specialization · Cohort 2024

Data Science to Optimize Cardiovascular Disease Prevention

Diabetes and obesity are significant risk factors for cardiovascular disease; however, recent advancements in medications, particularly Glucagon-Like Peptide-1 (GLP-1) agonists and similar drugs, have proven highly effective in protecting patients with these conditions from cardiovascular events. Our project focuses on investigating the impact of this class of medications on patients with obesity, diabetes, and other comorbidities using electronic health record data. We apply statistical methodologies, specifically Target Trial Emulation, to simulate randomized clinical trials and analyze real-world data.

Read the final report (PDF)

See it in the program report (PDF)

With KAUST Academy

All alumni

Want your entry updated or removed? Contact us.